Latest Regulatory News

Woodside Energy has raised its 2025 production guidance following a 1% increase in quarterly output, while progressing key projects like Scarborough and Beaumont New Ammonia on schedule. The company also secured long-term LNG supply deals and received critical regulatory approvals.

Evergreen Lithium has secured key regulatory approvals to begin reverse circulation drilling at its Mt Monger Gold Project, targeting high-potential gold prospects Duchess of York and Kiaki Soaks. The campaign aims to unlock valuable insights and guide further exploration in 2026.

TrivarX has completed recruitment of 60 patients in its US veteran-focused mental health trial, advancing validation of its novel single-lead ECG algorithm for depression screening. Positive interim results from 27 patients set the stage for full data release and commercial discussions.

Ballard Mining’s September quarter report highlights promising drilling results at its Mt Ida Gold Project and secures final approvals for a 2.0 Mtpa processing plant, underpinning its development ambitions.

Frontier Energy secures 88.06 MW of peak capacity credits for its Waroona Renewable Energy Project, guaranteeing $160 million in revenue over five years and underpinning its financing strategy.

Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.

Aura Energy has made significant strides in funding and development of its Tiris Uranium Project in Mauritania, while legislative progress in Sweden could unlock value at its Häggån Polymetallic Project. Rising uranium prices and secured offtake agreements underpin a positive outlook.

Miramar Resources has granted Future Battery Minerals an exclusive option to acquire its Randalls Project for up to A$800,000, enabling a strategic refocus on its core gold and critical minerals assets.

BPM Minerals has secured the Forelands Gold Project with promising high-grade intercepts and divested its Claw Gold Project to Capricorn Metals, bolstering its cash position ahead of upcoming drilling.

Sarama Resources has completed the third tranche of its A$2.7 million equity placement, raising A$100,000 to advance exploration at its Cosmo Gold Project and support ongoing arbitration efforts.

Lynch Group Holdings Limited proposes a scheme of arrangement for acquisition by Hasfarm Bidco at a 23% premium, with unanimous board support and an independent expert endorsement. Shareholders will vote in November on a deal that would delist Lynch from the ASX.

EMVision Medical Devices has closed its $2 million Share Purchase Plan ahead of schedule due to strong investor demand, signaling robust market interest in its neurodiagnostic technology.